Form 483s

FDA Form 483 Database

Every Form 483 on record, with its observations, the regulations cited, and the site and investigators behind it.

6,103

Investigators

232,103

Sites

148,507

Form 483s

88,971

Observations

Category
Year
Sort

Oxalis Labs

Form 483 · April 24, 2026

Solan, India

Human Drugs

3

Observations

Issued by Anastasia M Shields, Karishma G Gopaul

View Form 483

Alcami Carolinas Corporation

Form 483 · April 22, 2026

Charleston, United States

Animal Drugs & Feeds

7

Observations

Issued by Sonya M Edmonds, Steven A Brettler

View Form 483

Silgan Unicep Packaging, LLC

Form 483 · April 2, 2026

Spokane, United States

Human Drugs

8

Observations

Issued by Crystal Monroy, Carolina D Vasquez

View Form 483

Valley Springs Artesian Gold, LLC

Form 483 · February 13, 2026

Portage, United States

Foods & Cosmetics

18

Observations

Issued by Peter T Erlandson

View Form 483

Patheon Italia S.p.A.

Form 483 · February 10, 2026

Monza, Italy

Biologics

1

Observations

Issued by Lewis K Antwi, Peng Zhou

View Form 483

Alcami Carolinas Corporation

Form 483 · February 6, 2026

Charleston, United States

Human Drugs

6

Observations

Issued by Brandy N Lepage, Victoria Spivak

View Form 483

Fenwal International, Inc.

Form 483 · February 5, 2026

Maricao, United States

Biologics

9

Observations

Issued by Scott T Ballard, Ramon L Gonzalez-Prieto

View Form 483

Excel Vision

Form 483 · January 22, 2026

Annonay, France

Human Drugs

13

Observations

Issued by Justin A Boyd, Khoa Nathan V Tran, Karen A Briggs

View Form 483

PPD Development Ireland Ltd.

Form 483 · December 19, 2025

Athlone, Ireland

Biologics

1

Observations

Issued by Peng Zhou, Thai D Truong

View Form 483

Simtra US LLC

Form 483 · December 11, 2025

Bloomington, United States

Biologics

2

Observations

Issued by Priscilla M Pastrana, Lizaida Perez

View Form 483

MD Wholesale Foods LLC

Form 483 · December 3, 2025

Hyattsville, United States

Foods & Cosmetics

10

Observations

Issued by Mohamad A Chahine, Karen A Spencer, Eric L Vangraafeiland, Kadija R Karimu

View Form 483

Chartwell Pharmaceuticals Congers, LLC

Form 483 · November 18, 2025

Congers, United States

Human Drugs

15

Observations

Issued by Lata C Mathew, Mindy M Chou, Syeda N Mahazabin

View Form 483

Grand River Aseptic Manufacturing Inc.

Form 483 · November 4, 2025

Caledonia, United States

Human Drugs

2

Observations

Issued by Jacob G Lutz

View Form 483

Catalent Greenville Inc

Form 483 · October 24, 2025

Greenville, United States

Human Drugs

3

Observations

Issued by Nicole E Knowlton, Santos E Camara

View Form 483

Zhejiang Jingxin Pharmaceutical Co., Ltd

Form 483 · October 17, 2025

Shaoxing, China

Human Drugs

2

Observations

Issued by Carolina D Vasquez

View Form 483

Bactolac Pharmaceutical, Inc.

Form 483 · September 24, 2025

Hauppauge, United States

Foods & Cosmetics

5

Observations

Issued by Meredith P Soehl

View Form 483

United Laboratories Manufacturing, LLC

Form 483 · August 15, 2025

Carrollton, United States

Human Drugs

8

Observations

Issued by Shelby N Turner, Mercedes N Overton

View Form 483

Surmasis Pharmaceutical, LLC

Form 483 · August 1, 2025

Des Moines, United States

Human Drugs

4

Observations

Issued by Katherine E Jacobitz, Cecilia H Kieu, Aranjeet Singh

View Form 483

Seaway Pharma Inc.

Form 483 · June 18, 2025

Massena, United States

Human Drugs

11

Observations

Issued by Edmund F Mrak, Ifechimere I Okafor

View Form 483

Pharmcore Inc. dba Hallandale Pharmacy

Form 483 · June 13, 2025

Fort Lauderdale, United States

Human Drugs

2

Observations

Issued by Logan T Williams

View Form 483

Lux Therapeutics LLC

Form 483 · June 6, 2025

Brookhaven, United States

Biologics

7

Observations

Issued by Mizanne E Lewis, Jannet M Peroti, Nerming V Briones

View Form 483

Octapharma Plasma Inc.

Form 483 · June 5, 2025

Sparks, United States

Biologics

2

Observations

Issued by Shelley H Beausoleil

View Form 483

Universal Packaging Systems, Inc.

Form 483 · May 29, 2025

Chino, United States

Human Drugs

6

Observations

Issued by Darren S Brown, Navneet Kaur, Ngozi G Offor

View Form 483

The Maros Group, LLC

Form 483 · May 28, 2025

Phoenix, United States

Foods & Cosmetics

8

Observations

Issued by Megan K Rand

View Form 483

FAQ

Questions about FDA Form 483s

Finding a company's 483s, reading one, and what happens after it is issued.

Where can I find FDA 483 reports?

Right here. The Atlas Form 483 database lets you search 483 reports by company, facility, investigator, product area, and year, and each report opens with its observations, the regulations cited, and the investigators who issued it. A recent example is the Form 483 issued to Silgan Unicep Packaging in Spokane in April 2026, with eight observations.

How do I look up the 483s issued to a company?

Search the company or facility name above, then narrow it by year or product area. Every result links to the facility's page, where all of its 483s sit in one inspection history, and a recurring citations section shows whether the same regulations keep coming back. You can also start from the FDA facility lookup and search by company or city.

What does an FDA Form 483 contain?

A Form 483 lists, in numbered observations, the conditions an FDA investigator saw during an inspection that may violate FDA requirements, along with the facility, the inspection dates, and the investigators who signed it. It is not a final finding. FDA classifies the inspection afterwards as NAI, VAI, or OAI, which our guide to NAI, VAI, and OAI classifications explains.

How long does a company have to respond to a Form 483?

Fifteen business days. There is no legal requirement to respond, but FDA considers responses received within 15 business days of the 483's issue date before deciding whether to send a warning letter. A response that holds up acknowledges each observation, finds the root cause, and commits to dated corrective actions, as our Form 483 response guide shows.

What happens after a company receives a Form 483?

FDA reviews the 483, the investigator's report, and the company's response, then classifies the inspection. Many inspections that end with a 483 are classified VAI, with no regulatory action. An OAI classification can lead to a warning letter and, for a foreign facility, an import alert. Each facility page here shows which of its inspections ended in a warning letter.

Full 483 reports

Get the verbatim text behind every Form 483

Source PDFs, every observation in full, and the company's written response wherever Atlas holds them, so you see exactly what was cited and how it was answered.

  • Alerts when a company you follow receives a new 483
  • Whether a 483's citations escalated to a warning letter
  • Citation trends by regulation, product area, and year